News

CBIZ Exceeds Expectations with Strong Q3 Financial Results

CBIZ Exceeds Expectations with Strong Q3 Financial Results

CBIZ Reports Impressive Third Quarter Financial Growth

Key Takeaways:

  • Total revenue reached $693.8 million, reflecting a robust increase of 58.1%.
  • Net income reported at $30.1 million, showing a slight decline of 14.1% year-over-year; GAAP EPS stands at $0.48, down 31.4%.
  • Adjusted EBITDA rose to $120.0 million, a year-over-year increase of 57.4%, with adjusted diluted EPS at $1.01, citing a growth of 8.5%.

Overview of Financial Performance

CBIZ, Inc. (NYSE: CBZ), recognized as a leading provider of professional services, has reported commendable financial results for the third quarter of 2025. The company’s revenue jumped significantly, attributed to improved performance in core and recurring essential services alongside favorable market conditions.

Jerry Grisko, the President and CEO of CBIZ, expressed satisfaction with the quarter's outcomes, stating, "We believe this quarter's results validate our business model and strategic acquisitions. The combined strengths we harnessed from the Marcum acquisition have exceeded our initial expectations, particularly in achieving synergies. We are now better positioned to cater to our clients and prospects, especially within the thriving U.S. middle-market sector."

Revenue and Income Analysis

For the third quarter ending September 30, 2025, total revenue surged to $693.8 million compared to $438.9 million in the same quarter of the previous year. The net income for this period was reported at $30.1 million, which translates to $0.48 per diluted share. In contrast, prior year's figures were $35.1 million and $0.70 per diluted share, respectively.

The adjusted numbers indicate continued growth, as the adjusted net income stood at $63.5 million, up from $46.9 million a year earlier. This reflects a resilient 8.5% increase in adjusted earnings per diluted share, rising from $0.93 to $1.01 within a year. Furthermore, the adjusted EBITDA saw a substantial 57.4% uplift, now totaling $120.0 million, as compared to $76.3 million previously.

Projections and Future Outlook

Looking ahead, CBIZ aims to achieve total revenue in the range of $2.8 billion to $2.95 billion for the full fiscal year. The company anticipates an effective tax rate around 29% and projects a weighted average fully diluted share count of approximately 65.0 million shares. Guidance for GAAP fully diluted earnings per share is forecasted between $1.97 to $2.02, while adjusted fully diluted earnings per share is expected to fall between $3.60 to $3.65. Adjusted EBITDA is projected to range from $450 million to $456 million.

Key Highlights from Nine Months

For the nine-month period concluding September 30, 2025, CBIZ demonstrated exceptional performance with total revenue of $2.2 billion, representing a 63.7% increase from $1.4 billion observed in the same timeframe the previous year. The net income reflects significant progress, reporting $194.9 million, marking a 47.9% rise from the prior year. This translates to a GAAP EPS of $3.06, continuing a positive trend indicated by a 16.8% increase.

Adjusted earnings for the nine-month mark yield an adjusted net income amounting to $271.9 million, compared to $158.6 million in the previous period. This includes an adjusted earnings per share increase of 35.6%, moving to $4.27 from $3.15.

Conference Call Insights

CBIZ has scheduled a conference call at 5 p.m. (ET) today to elaborate on its financial results for the third quarter. Importantly, the call will be accessible through a live webcast, and a recording will be available post-call for further insights.

About CBIZ, Inc.

CBIZ, Inc. (NYSE: CBZ) specializes in delivering comprehensive professional services targeting middle-market businesses. By leveraging industry-specific knowledge across sectors such as accounting, tax, and advisory services, CBIZ empowers clients to navigate complexities and enhance growth opportunities. With a dedicated team of over 10,000 professionals, CBIZ operates across 160+ locations nationwide, fostering valuable relationships to drive success.

Frequently Asked Questions

What were CBIZ's total revenues in the third quarter of 2025?

Total revenues reached $693.8 million, marking a 58.1% increase from the prior year.

How does CBIZ's net income for Q3 2025 compare to the previous year?

Net income for Q3 2025 was $30.1 million, a decrease of 14.1% from the previous year's $35.1 million.

What is the anticipated revenue range for CBIZ for the full fiscal year?

CBIZ expects total revenue to be in the range of $2.8 billion to $2.95 billion for the full fiscal year.

What is the adjusted EBITDA for the nine-month period ending September 30, 2025?

Adjusted EBITDA for this period was $475.6 million, an impressive increase compared to the prior year's figure.

What sectors does CBIZ provide professional services in?

CBIZ offers professional services across various sectors, including accounting, tax, advisory, insurance, and technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 89

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Yellow River Basin Firms Focus on Global Expansion

Updated Category News Views 58

Shandong's Bold Move on the Global Stage Imagine the bustling city of Jinan, Shandong's capital, humming with the energy of ambitious enterprises ready to leap into the global arena. That's exactly what unfolded at the conference aimed at forging international ties under the Belt and Road Initiative (BRI). For those out of the loop, this ain't just another business...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 73

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading
Smirnoff Launches Marvel Event with $12.99 Offer

Updated Category News Views 114

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 141

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
JumpCloud Tackles Compliance in the AI Era

Updated Category News Views 110

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 111

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading
Jamaica's Tourism Rebounds Post-Hurricane Challenges

Updated Category News Views 128

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Continue Reading
Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Updated Category News Views 25

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women in HVACR: Join the 2025 Convention

Updated Category News Views 247

Women in HVACR Announces Annual Convention The nonprofit organization is now accepting registrations for an upcoming conference aimed at empowering women in the HVACR industry. Details About the Conference Women in HVACR (WHVACR) has confirmed that it will host its annual conference at the Red Rock Casino, Resort & Spa. Registration is currently open, inviting...

Continue Reading
Exploring Growth in the Global Personalized Gifts Industry

Updated Category News Views 191

Overview of the Personalized Gifts Market In today's world, the personalized gifts market is on the verge of a significant expansion, projected to increase by USD 10.76 billion by 2029. This remarkable growth results from various factors, including advancements in technology and changing consumer preferences. More than ever, people value unique and heartwarming gifts that...

Continue Reading
Cellectar Biosciences Sees Growth Amid Drug Development Advances

Updated Category News Views 252

Cellectar Biosciences Financial Performance and Recent Developments Cellectar Biosciences, Inc. (NASDAQ: CLRB), a biopharmaceutical company dedicated to cancer treatment, has announced its financial results for the year ending December 31, 2024. As it advances towards new treatment protocols and expands into clinical trials, the firm reveals a positive outlook for growth....

Continue Reading
Fair Play Menarini: Celebrating 30 Years in Florence

Updated Category News Views 11

Honoring Athletes with Integrity In this fast-paced world of competitive sports, it's easy to get lost in the glitz and glamour, the medals, the money, the fame—heck, even the scandals. Yet, there's an award out there tipping its hat to those who've kept their heads straight and their hearts clean, come hell or high water. We had ourselves a real humdinger of a night in...

Continue Reading
Vidu Unveils Innovative AI Technology to Transform Photography

Updated Category News Views 350

Vidu Revamps the Photography Landscape with AI Innovation ShengShu Technology presents Vidu's groundbreaking Reference-to-Image feature, primed to transform our understanding of photography. This innovative image compositing tool offers a unique capability to generate lifelike photographs from a collection of seven reference images, while ensuring the utmost consistency...

Continue Reading
reckenridge Launches Everolimus Tablets to Enhance Patient Care"> Continue Reading